EICHOR
● Active Not Recruiting
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Condition: Open Angle Glaucoma · Ocular Hypertension · Sponsor: Santen Pharmaceutical Co., Ltd.
About this study
This is a Phase III Study that includes a single arm, open-label, multi-dose PK study cohort and a randomized, evaluator-masked, active drug-control multicenter study. Subjects diagnosed with POAG (Primary Open Angle Glaucoma) or OHT (Ocular Hypertension) who meet eligibility criteria will washout of their current IOP lowering medication(s), if any. The study will investigate plasma pharmacokinetics of multi-dose 0.002% DE-117B eye drops (1 drop at a time administered once daily for 7 days) in Chinese subjects with primary open angle glaucoma or ocular hypertension. It will investigate the safety of multi-dose 0.002% DE-117B eye drops (1 drop at a time administered once daily for 7 days) in Chinese subjects with primary open angle glaucoma or ocular hypertension. There will be a bridging cohort and extension follow-up phase
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (24)
| Beijing Chao-Yang Hospital, Capital Medical University | Beijing, China | — |
| Beijing Hospital | Beijing, China | — |
| Beijing Tongren Hospital, Capital Medical University | Beijing, China | — |
| Peking University Third Hospital | Beijing, China | — |
| Zhongshan Ophthalmic Center | Guangzhou, China | — |
| Affiliated Hospital of Guizhou Medical University | Guiyang, China | — |
| The Second Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou, China | — |
| Zhejiang Provincial People's Hospital | Hangzhou, China | — |
| Daqing People's Hospital | Heilongjiang, China | — |
| Jinan Second People's Hospital (Jinan eye hospital) | Jinan, China | — |
| The Second Hospital & Clinical Medicial Lanzhou University | Lanzhou, China | — |
| Luoyang third people's hospital | Luoyang, China | — |
+ 12 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06666855